Zobrazeno 1 - 10
of 184
pro vyhledávání: '"Birgit C P Koch"'
Autor:
Moska Hassanzai, Fadime Adanç, Birgit C P Koch, Nelianne J Verkaik, Jakob van Oldenrijk, Jorg L de Bruin, Brenda C M de Winter, Hein A W van Onzenoort
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 10 (2023)
Background: Outpatient Parenteral Antimicrobial Therapy (OPAT) is considered a patient-friendly and cost-effective practice. Patients in the OPAT service can be at risk for developing adverse events. Due to extensive variations in practice, guideline
Externí odkaz:
https://doaj.org/article/194be167cd79494b88bae650d4dfb2b7
Autor:
Rebecca A. Hermans, Lisa T. Ringeling, Kajie Liang, Sanne M. Kloosterboer, Brenda C. M. de Winter, Manon H. J. Hillegers, Birgit C. P. Koch, Bram Dierckx
Publikováno v:
BMC Psychiatry, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Antipsychotic drugs are an important part of the treatment of irritability and aggression in children with an autism spectrum disorder (ASD). However, significant weight gain and metabolic disturbances are clinically relevant side
Externí odkaz:
https://doaj.org/article/ce3abc5704a4411ab39fb8626c3ff432
Autor:
Eloísa Rubio‐Beltrán, Rianne M. Schoon, Jeffrey van denBerg, Catharina C. M. Schuiling‐Veninga, Birgit C. P. Koch, Carlos M. Villalón, Jorie Versmissen, A. H. Jan Danser, Anton H. van denMeiracker, Khatera Ibrahimi, Antoinette MaassenVanDenBrink
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 9, Iss 9, Pp 1405-1416 (2022)
Abstract Objective Assess whether propranolol modulates the trigeminovascular system in both men and women. Methods We investigated the effect of propranolol (80 mg, 90 min after oral administration, corresponding to Tmax) on the increase in dermal b
Externí odkaz:
https://doaj.org/article/6a99da2c58ec42c88c8c695660a8786d
Autor:
Tim M. J. Ewoldt, Alan Abdulla, Puck van den Broek, Nicole Hunfeld, Soma Bahmany, Anouk E. Muller, Diederik Gommers, Suzanne Polinder, Henrik Endeman, Inge Spronk, Birgit C. P. Koch
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Recent studies demonstrated that failure of achieving pharmacodynamic targets of commonly used antibiotics is common in critically ill patients. Therapeutic drug monitoring (TDM) can contribute to optimize the exposure of beta-lac
Externí odkaz:
https://doaj.org/article/ddd085123370440f945e9846c156ba88
Autor:
Bram C. Agema, G. D. Marijn Veerman, Christi M. J. Steendam, Daan A. C. Lanser, Tim Preijers, Cor van der Leest, Birgit C. P. Koch, Anne-Marie C. Dingemans, Ron H. J. Mathijssen, Stijn L. W. Koolen
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Background: Osimertinib is the cornerstone in the treatment of epidermal growth factor receptor-mutated non-small cell lung cancer (NSCLC). Nonetheless, ±25% of patients experience severe treatment-related toxicities. Currently, it is impossible to
Externí odkaz:
https://doaj.org/article/0954342ab709469f8e0750b0bc63082a
Autor:
Alan Abdulla, Annemieke Dijkstra, Nicole G. M. Hunfeld, Henrik Endeman, Soma Bahmany, Tim M. J. Ewoldt, Anouk E. Muller, Teun van Gelder, Diederik Gommers, Birgit C. P. Koch
Publikováno v:
Critical Care, Vol 24, Iss 1, Pp 1-12 (2020)
Abstract Background Early and appropriate antibiotic dosing is associated with improved clinical outcomes in critically ill patients, yet target attainment remains a challenge. Traditional antibiotic dosing is not suitable in critically ill patients,
Externí odkaz:
https://doaj.org/article/0f154ec3e09242a69e716dee85ab5a45
Autor:
Angela Elma Edwina, Birgit C. P. Koch, Anouk E. Muller, Valentin al Jalali, Peter Matzneller, Markus Zeitlinger, Sebastiaan D. T. Sassen
Publikováno v:
European Journal of Clinical Pharmacology, 79(6), 775-787. Springer-Verlag
Purpose A population pharmacokinetic model of fosfomycin was developed in healthy volunteers after intravenous administration, and different dosing regimens were evaluated in terms of the probability of target attainment for Escherichia coli using bo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::743ad422e173bcc2993316c0b4b58749
https://pure.eur.nl/en/publications/0ab58750-99e3-4cf7-bbbc-fdfdf2fb1327
https://pure.eur.nl/en/publications/0ab58750-99e3-4cf7-bbbc-fdfdf2fb1327
Autor:
Eveline E. Roelofsen, Brenda C. M. de Winter, Heleen van der Spek, Susan Snijders, Birgit C. P. Koch, Sanne van den Berg, Anouk E. Muller
Publikováno v:
Antibiotics, Vol 11, Iss 8, p 1049 (2022)
For decades, flucloxacillin has been used to treat methicillin-susceptible Staphylococcus aureus (MSSA). Little is still known about its pharmacodynamics (PD). The present study aimed to determine the pharmacokinetic (PK)/PD index and the PD-index va
Externí odkaz:
https://doaj.org/article/64a9676c538f474fb6d6c976d1244f6a
Autor:
Alan Abdulla, Elma Edwina, Robert B. Flint, Karel Allegaert, Enno D. Wildschut, Birgit C. P. Koch, Matthijs de Hoog
Publikováno v:
Frontiers in Pediatrics, Vol 9 (2021)
Optimal pharmacotherapy in pediatric patients with suspected infections requires understanding and integration of relevant data on the antibiotic, bacterial pathogen, and patient characteristics. Because of age-related physiological maturation and no
Externí odkaz:
https://doaj.org/article/1ac6629dbb4b44ca84dd3e434699680f
Autor:
Ruben, Malmberg, Michiel, Zietse, Daphne W, Dumoulin, Jeroen J M A, Hendrikx, Joachim G J V, Aerts, Astrid A M, van der Veldt, Birgit C P, Koch, Stefan, Sleijfer, Roelof W F, van Leeuwen
Publikováno v:
The Lancet Oncology. 23:e552-e561
Immune checkpoint inhibitors have revolutionised cancer treatment by offering durable responses to many patients with solid and haematological cancers. The high prices and increasing use of immune checkpoint inhibitors put considerable strain on heal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95f95a1398bb24def3d631fb9628db0c
https://doi.org/10.1016/s1470-2045(22)00554-x
https://doi.org/10.1016/s1470-2045(22)00554-x